Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PIEX 6 is a standardized, plant-identical cannabis extract developed by Becanex. It is a raw concentrate containing 70% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD), with a stable, characteristic terpene profile derived from a specific, defined cannabis flower strain. Designed for pharmacy compounding, PIEX 6 is intended to maintain the natural ratio of cannabinoids and terpenes of the source flower to provide consistent and predictable therapeutic effects. It can be processed into various compounded preparations, such as inhalation formulations, oral oil solutions, capsules, suppositories, and topical products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PIEX 6.